一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

返回ChemicalBook首頁>CAS數(shù)據(jù)庫列表>223132-37-4

223132-37-4

中文名稱 5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑啉二酮
英文名稱 inolitazone
CAS 223132-37-4
分子式 C27H26N4O4S
分子量 502.58
MOL 文件 223132-37-4.mol
更新日期 2023/03/17 20:03:07
223132-37-4 結構式 223132-37-4 結構式

基本信息

中文別名
伊諾他酮
伊諾他酮二鹽酸鹽
5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑啉二酮
英文別名
RS5444
CS-1166
Efatutazone
inolitazone
Inolitazone (CS-7017)
Inolitazone Efatutazone
5-[[4-[[6-(4-Amino-3,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]-2,4-thiazolidinedione
2,4-Thiazolidinedione, 5-[[4-[[6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]-
所屬類別
生物化工:激動劑抑制劑

物理化學性質

沸點765.7±60.0 °C(Predicted)
密度1.39
儲存條件-20°C儲存
溶解度DMSO
酸度系數(shù)(pKa)6.34±0.50(Predicted)
形態(tài)粉末

安全數(shù)據(jù)

危險性符號(GHS)有害 (GHS07)
GHS07
警示詞警告
危險性描述H302-H315-H319-H335

常見問題列表

生物活性
Inolitazone(RS5444; CS-7017)是新型PPARγ高親和性激動劑,EC50為rosiglitazone的五十分之一,對于不表達PPARγ的RIE細胞無抑制性。
靶點

PPARγ

體外研究

Inolitazone (RS5444) upregulates the cell cycle kinase inhibitor, p21 WAF1/CIP1 . Silencing p21 WAF1/CIP1 rendered cells insensitive to Inolitazone. A 10 nM dose of Inolitazone activates PPARγ:RXRα-dependent transcription as demonstrated in a transient transfection assay utilizing a PPRE response element fused to a luciferase reporter gene (PPRE3-tk-luc). DRO cells are treated in culture with Inolitazone, Rosiglitazone, or Troglitazone at the indicated concentrations. DRO cells are transiently transfected with PPRE3-tk-luc to examine effective concentrations at which EC 50 occurs. The EC 50 s are 1 nM (Inolitazone), 65 nM (Rosiglitazone) and 631 nM (Troglitazone). Similarly, the calculated inhibitory concentration at IC 50 is 0.8 nM for Inolitazone, 75 nM for Rosiglitazone, and 1412 nM for Troglitazone. Inolitazone specifically activates PPARγ, but not PPARα or PPARδ. Exposure of 10 nM Inolitazone following transient transfection with the appropriate PPAR isoform (γ, α, or δ) and PPAR response element linked to a luciferase reporter in RIE rat small intestinal cell line, which does not express PPARs, yields increased luciferase activity only in the presence of PPARγ and PPRE3-tk-luc. DRO cells are growth inhibited by 10 nM Inolitazone (RS5444) through a PPARγ-dependent mechanism.

體內研究

Inolitazone (RS5444) plus Paclitaxel demonstrate additive antiproliferative activity in cell culture and minimal ATC tumor growth. When Inolitazone is administered in the diet to athymic nude mice prior to DRO tumor cell implantation, tumor growth is inhibited in a dose responsive fashion. At the highest dose, 0.025% Inolitazone inhibits growth on day 32 by 94.4% as compared to that of control. In this treatment group, five of 10 animals do not develop demonstrable tumors. In the 0.0025% treatment group, tumor growth is inhibited by 62.3% compared to that of control on day 32 while the 0.00025% dose demonstrated no growth inhibitory activity as compared to control. Tumors is nest allowed to establish in the mouse and began 0.025% Inolitazone treatment of mice 1 week after DRO or ARO tumor cell implantation. Inolitazone treated animals demonstrate tumor growth inhibition of 68.9% in DRO tumors and 48.3% in ARO tumors as compared to that of their respective controls on day 35.

"223132-37-4" 相關產(chǎn)品信息
106-42-3 55406-53-6 100-44-7 87-62-7 121-69-7
禹州市| 北安市| 灯塔市| 福贡县| 民乐县| 米脂县| 靖安县| 大厂| 怀化市| 平泉县| 洛宁县| 宁陵县| 澄江县| 乌兰察布市| 凤山县| 怀化市| 西贡区| 曲沃县| 南靖县| 舒城县| 舟山市| 寿宁县| 玉屏| 牡丹江市| 景泰县| 临邑县| 宜兰县| 磐安县| 阳城县| 拉萨市| 柘城县| 永年县| 衡山县| 沅江市| 崇左市| 兴化市| 定边县| 万荣县| 浪卡子县| 石棉县| 九台市|